Did not become law. It stopped in the Senate's Insurance and Real Estate Committee on March 11, 2022. The 2022 session has ended.
2022 Regular Session
Senate Bill 415
AN ACT CONCERNING STEP THERAPY, ADVERSE DETERMINATION AND UTILIZATION REVIEWS.
What it does
The synopsis the General Assembly published with the bill.
To (1) prohibit certain health carriers from requiring the use of step therapy for drugs prescribed to treat behavioral health conditions or chronic, disabling or life-threatening conditions or diseases; (2) redefine "clinical peer" for the purposes of adverse determination and utilization reviews; (3) require health carriers to bear the burden of proving that certain health care services under adverse determination or utilization review are not medically necessary; and (4) require health carriers to provide certain clinical peers with authority to reverse initial adverse determinations.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
March 10 to March 11, 2022, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the SenateMar 10 to Mar 11 · stopped1 day
Insurance and Real Estate CommitteeMar 10 to Mar 11 · stopped1 day
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Mar 10 – Mar 11
- Mar 10Introduced and sent to Insurance and Real Estate Committee
- Mar 11Heard in Insurance and Real Estate Committee
All 2 actions, as published
- Mar 10REF. TO JOINT COMM. ONBoth houses
- Mar 11PUBLIC HEARINGBoth houses